Geneos Wealth Management’s iShares S&P 500 Value ETF IVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.29M Sell
43,974
-131
-0.3% -$28.4K 0.22% 106
2025
Q4
$9.35M Buy
44,105
+434
+1% +$91K 0.23% 108
2025
Q3
$9.02M Buy
43,671
+225
+0.5% +$45.2K 0.23% 111
2025
Q2
$8.49M Sell
43,446
-44,201
-50% -$8.23M 0.21% 125
2025
Q1
$16.7M Buy
87,647
+45,033
+106% +$8.71M 0.24% 102
2024
Q4
$8.13M Buy
42,614
+350
+0.8% +$69.4K 0.28% 75
2024
Q3
$8.33M Buy
42,264
+395
+0.9% +$75K 0.32% 71
2024
Q2
$7.62M Sell
41,869
-194
-0.5% -$35.3K 0.34% 66
2024
Q1
$7.86M Sell
42,063
-72
-0.2% -$12.8K 0.36% 62
2023
Q4
$7.33M Sell
42,135
-829
-2% -$133K 0.36% 59
2023
Q3
$6.61M Buy
42,964
+863
+2% +$139K 0.34% 65
2023
Q2
$6.79M Sell
42,101
-153
-0.4% -$23.5K 0.36% 60
2023
Q1
$6.41M Buy
42,254
+340
+0.8% +$51.4K 0.39% 55
2022
Q4
$6.08M Buy
41,914
+161
+0.4% +$23K 0.37% 62
2022
Q3
$5.37M Sell
41,753
-3,274
-7% -$464K 0.37% 59
2022
Q2
$6.27M Buy
45,027
+7
+0% +$1.03K 0.31% 69
2022
Q1
$7.01M Sell
45,020
-885
-2% -$136K 0.3% 69
2021
Q4
$7.19M Buy
45,905
+1,170
+3% +$178K 0.27% 80
2021
Q3
$6.59M Sell
44,735
-14,290
-24% -$2.13M 0.25% 83
2021
Q2
$8.79M Sell
59,025
-3,591
-6% -$529K 0.34% 60
2021
Q1
$9.17M Sell
62,616
-445
-0.7% -$59.9K 0.26% 93
2020
Q4
$8.39M Buy
63,061
+22,002
+54% +$2.66M 0.34% 64
2020
Q3
$4.54M Buy
41,059
+2,807
+7% +$318K 0.24% 97
2020
Q2
$4.02M Sell
38,252
-610
-2% -$64.7K 0.22% 105
2020
Q1
$3.7M Sell
38,862
-1
-0% -$119 0.25% 92
2019
Q4
$5.06M Sell
38,863
-158
-0.4% -$19.7K 0.27% 106
2019
Q3
$4.63M Sell
39,021
-13
-0% -$1.52K 0.28% 96
2019
Q2
$4.55M Buy
39,034
+3,871
+11% +$443K 0.28% 95
2019
Q1
$3.96M Sell
35,163
-455
-1% -$50K 0.26% 101
2018
Q4
$3.58M Sell
35,618
-10
-0% -$1.09K 0.26% 102
2018
Q3
$4.13M Sell
35,628
-521
-1% -$59.8K 0.27% 100
2018
Q2
$3.98M Buy
36,149
+1,590
+5% +$176K 0.31% 89
2018
Q1
$3.78M Sell
34,559
-1,071
-3% -$122K 0.33% 82
2017
Q4
$4.07M Buy
35,630
+1,634
+5% +$181K 0.36% 80
2017
Q3
$3.67M Buy
33,996
+137
+0.4% +$14.5K 0.36% 76
2017
Q2
$3.55M Buy
33,859
+1,168
+4% +$122K 0.36% 73
2017
Q1
$3.4M Buy
32,691
+292
+0.9% +$30.3K 0.35% 74
2016
Q4
$3.28M Buy
32,399
+1,759
+6% +$172K 0.43% 58
2016
Q3
$2.91M Buy
30,640
+2,428
+9% +$231K 0.39% 63
2016
Q2
$2.62M Buy
28,212
+3,600
+15% +$330K 0.38% 63
2016
Q1
$2.22M Buy
+24,612
New +$2.1M 0.34% 69

Other funds holding IVE

Geneos Wealth Management's IVE Position: Q1 2026 in Review

Geneos Wealth Management reduced its iShares S&P 500 Value ETF (IVE) stake by 0.3% in Q1 2026, selling an estimated $28.4K and leaving 43,974 shares worth $9.29M. The position accounts for 0.22% of the portfolio, ranked #106.

Geneos Wealth Management first reported a position in IVE in Q1 2016 and has held it in 41 quarters since. The position peaked at $16.7M in Q1 2025. 1,704 funds tracked by Wall St. Rank hold IVE as of Q1 2026.

  • Geneos Wealth Management held 43,974 shares of iShares S&P 500 Value ETF worth $9.29M as of Q1 2026.
  • Geneos Wealth Management sold 131 iShares S&P 500 Value ETF shares in Q1 2026, an estimated $28.4K.
  • iShares S&P 500 Value ETF made up 0.22% of Geneos Wealth Management's portfolio in Q1 2026, its #106 holding.
  • Geneos Wealth Management first reported a position in iShares S&P 500 Value ETF in Q1 2016 and has held it in 41 quarters since.
  • Geneos Wealth Management's iShares S&P 500 Value ETF position peaked at $16.7M in Q1 2025.
  • 1,704 funds tracked by Wall St. Rank held iShares S&P 500 Value ETF as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.